These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
382 related items for PubMed ID: 8626392
1. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. Beerli RR, Hynes NE. J Biol Chem; 1996 Mar 15; 271(11):6071-6. PubMed ID: 8626392 [Abstract] [Full Text] [Related]
2. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. Riese DJ, Kim ED, Elenius K, Buckley S, Klagsbrun M, Plowman GD, Stern DF. J Biol Chem; 1996 Aug 16; 271(33):20047-52. PubMed ID: 8702723 [Abstract] [Full Text] [Related]
3. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4. Chen X, Levkowitz G, Tzahar E, Karunagaran D, Lavi S, Ben-Baruch N, Leitner O, Ratzkin BJ, Bacus SS, Yarden Y. J Biol Chem; 1996 Mar 29; 271(13):7620-9. PubMed ID: 8631797 [Abstract] [Full Text] [Related]
4. Neu differentiation factor inhibits EGF binding. A model for trans-regulation within the ErbB family of receptor tyrosine kinases. Karunagaran D, Tzahar E, Liu N, Wen D, Yarden Y. J Biol Chem; 1995 Apr 28; 270(17):9982-90. PubMed ID: 7730382 [Abstract] [Full Text] [Related]
5. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Graus-Porta D, Beerli RR, Hynes NE. Mol Cell Biol; 1995 Mar 28; 15(3):1182-91. PubMed ID: 7532277 [Abstract] [Full Text] [Related]
6. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. EMBO J; 1997 Apr 01; 16(7):1647-55. PubMed ID: 9130710 [Abstract] [Full Text] [Related]
7. Differential activation of ErbB receptors in the rat olfactory mucosa by transforming growth factor-alpha and epidermal growth factor in vivo. Ezeh PI, Farbman AI. J Neurobiol; 1998 Nov 05; 37(2):199-210. PubMed ID: 9805267 [Abstract] [Full Text] [Related]
8. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Pinkas-Kramarski R, Lenferink AE, Bacus SS, Lyass L, van de Poll ML, Klapper LN, Tzahar E, Sela M, van Zoelen EJ, Yarden Y. Oncogene; 1998 Mar 12; 16(10):1249-58. PubMed ID: 9546426 [Abstract] [Full Text] [Related]
9. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Beerli RR, Graus-Porta D, Woods-Cook K, Chen X, Yarden Y, Hynes NE. Mol Cell Biol; 1995 Dec 12; 15(12):6496-505. PubMed ID: 8524214 [Abstract] [Full Text] [Related]
10. ErbB kinases and NDF signaling in human prostate cancer cells. Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ. Oncogene; 1997 Nov 27; 15(22):2705-16. PubMed ID: 9400997 [Abstract] [Full Text] [Related]
11. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4. Wang LM, Kuo A, Alimandi M, Veri MC, Lee CC, Kapoor V, Ellmore N, Chen XH, Pierce JH. Proc Natl Acad Sci U S A; 1998 Jun 09; 95(12):6809-14. PubMed ID: 9618494 [Abstract] [Full Text] [Related]
12. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells. Shin HS, Lee HJ, Nishida M, Lee MS, Tamura R, Yamashita S, Matsuzawa Y, Lee IK, Koh GY. Circ Res; 2003 Aug 22; 93(4):302-10. PubMed ID: 12869389 [Abstract] [Full Text] [Related]
13. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Ram TG, Ethier SP. Cell Growth Differ; 1996 May 22; 7(5):551-61. PubMed ID: 8732665 [Abstract] [Full Text] [Related]
14. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. Baulida J, Kraus MH, Alimandi M, Di Fiore PP, Carpenter G. J Biol Chem; 1996 Mar 01; 271(9):5251-7. PubMed ID: 8617810 [Abstract] [Full Text] [Related]
15. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells. Marte BM, Jeschke M, Graus-Porta D, Taverna D, Hofer P, Groner B, Yarden Y, Hynes NE. Mol Endocrinol; 1995 Jan 01; 9(1):14-23. PubMed ID: 7760847 [Abstract] [Full Text] [Related]
16. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis. Révillion F, Lhotellier V, Hornez L, Bonneterre J, Peyrat JP. Ann Oncol; 2008 Jan 01; 19(1):73-80. PubMed ID: 17962208 [Abstract] [Full Text] [Related]
17. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Ethier SP, Langton BC, Dilts CA. Mol Carcinog; 1996 Feb 01; 15(2):134-43. PubMed ID: 8599580 [Abstract] [Full Text] [Related]
18. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells. Ram TG, Kokeny KE, Dilts CA, Ethier SP. J Cell Physiol; 1995 Jun 01; 163(3):589-96. PubMed ID: 7775601 [Abstract] [Full Text] [Related]
19. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2. Ram TG, Dilts CA, Dziubinski ML, Pierce LJ, Ethier SP. Mol Carcinog; 1996 Mar 01; 15(3):227-38. PubMed ID: 8597535 [Abstract] [Full Text] [Related]
20. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells. Miyazaki Y, Hiraoka S, Tsutsui S, Kitamura S, Shinomura Y, Matsuzawa Y. Gastroenterology; 2001 Jan 01; 120(1):108-16. PubMed ID: 11208719 [Abstract] [Full Text] [Related] Page: [Next] [New Search]